Theremia is an AI-driven platform that designs drug derivatives to improve efficacy and tolerability across diverse demographics.

Theremia

Theremia | 781 followers on LinkedIn. AI for inclusive healthcare | Theremia is a pioneering health tech company focused on transforming drug development through advanced AI technologies. We specialize in optimizing drug derivatives for specific population subgroups, with a focus on neurological disorders. Our platform aims to improve treatment efficacy and reduce side effects, ultimately providing more personalized and effective healthcare solutions.

Co-founder & CTO of Theremia

Chloé Geoffroy

Theremia • ESCP • Product Manager

Thaïs Bach

AI engineer / CIFRE

Zeki Topçu

We're thrilled to announce that Theremia has raised a €3 million seed round led by Eurazeo and Salica Investments , with participation from several exceptional business angels! This funding will support the development of our precision medicine tool that enhance drug efficacy across diverse demographics. A special thank you to our amazing investors—including Maxime Huerre , Louis Bô , Issy Gordon , Nicholas Sharp , Maximilien Levesque , Olivier Vaury , Sofia Dahoune , Natasha Rostovtseva , Vincent Sebag , John Gridley , Nicolas Douay & Baptiste HAMEL (BetterAngle), Ophelia C , Entrepreneur First , Jordan GUYON , Antoine Dusséaux , Alexandre Depres , Pascale Witz , Claire Chappert Burucoa , — to our incredible team, and to Sibylle de Villeneuve for the PR campaign (see comments below)! 🧬 Stay tuned for more exciting updates as we embark on this journey!

Iris Maréchal

🧬 Ready to revolutionize biology with AI? Join us at the exclusive Bio x AI Hackathon hosted by Entrepreneur First , Theremia and :probabl. ! What’s at stake? 💯 An incredible opportunity to tackle challenging topics alongside brilliant minds, with guidance from experts like Vincent Maladière , from :probabl. (the top open-source library and creator of scikit-learn) and Chloé Geoffroy & Tristan Fauvel from Theremia ) 🏆 €2,000 Cash Prize for the winning team 🤞 Invitation to EF Selection Day for standout participants 👉 If you’re a biologist or machine learning expert with a passion for innovation, this is your chance to collaborate with top scientists, engineers, and AI enthusiasts to tackle biology's most ambitious challenges. Apply now to secure your spot and embark on a journey of innovation, teamwork, and discovery : https://lu.ma/nmqgrfws

We're excited to announce the launch of DayOne Health 4.0's 2024 cohort, featuring 15 innovative digital health startups from 8 countries. Selected from a record 170 applications, these companies will harness AI, data, and digital tools to advance clinical development, reinvent clinical trials, and enhance patient experience. Over the next six months, they will refine their value propositions, optimize their business models, and prepare for key collaborations with the life sciences industry. Welcome on board to all of them! 📄 Read the full cohort announcement here: https://lnkd.in/eTe4x9aq aimed analytics GmbH | BioT Medical | Bowhead Health | Delve Health | Ephion Health | Exploris Health AG | iLoF | MiiCare | OncoDecipher | Oncoustics | Senseera | Theremia | TOM Medications | VEIL.AI | Wemedoo AG

DayOne - Healthcare Innovation

🚀 Kicking off 2024 on a high note! Theremia has developed an AI-driven platform that leverages multi-scale algorithms to create optimized drug derivatives for specific population subgroups, with a primary focus on neurological disorders. Our goal is to revolutionize drug development by ensuring more personalized and effective treatments for patients. ➡ Immediate next step: We are thrilled to announce that Theremia has been selected to join the DayOne - Healthcare Innovation accelerator cohort 2024! This prestigious six-month hybrid program, focused on health tech innovation, will provide us with an invaluable opportunity to collaborate with leading experts and 15 other innovative startups at the intersection of #AI , #data , and #pharma . Through this program, we look forward to refining our platform, enhancing our business model, and preparing for impactful partnerships with pharmaceutical companies. A big thank you to DayOne - Healthcare Innovation , Cécile Tardy-Srinivasan , Natasha Rostovtseva for this incredible opportunity. We’re eager to share more updates on our journey! Congratulations to our fellow cohort members: aimed analytics GmbH | BioT Medical | Bowhead Health | Delve Health | Ephion Health | Exploris Health AG | iLoF | MiiCare | OncoDecipher | Oncoustics | Senseera | TOM Medications | VEIL.AI | Wemedoo AG #DayOneBasel #Cohort6 #HealthTech #AIinHealthcare #PharmaInnovation

Metric
Company Name	Theremia
Symbol
MSH ID	HEALTH:THEREMIA
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Pharmaceuticals
Country	FR
Stage
Employee Count
Website	theremia.health
LinkedIn	theremia
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

THER

HEALTH:THEREMIA

Theremia

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue